Patient Assistance Programs
 
Fighting AIDS in Africa
 
Bristol-Myers Squibb Foundation & Corporate Philanthropy
 
Product Integrity
 
Sustainability: Our Plan for Responsible Growth
 
Environment, Health & Safety Policy
 
Medical Education Grants And Charitable Contributions
 
Clinical Outcomes And Research Grants
 
Position On Key Issues

 

  » BMS.com Home » Corporate Responsibility » Corporate Membership Support
SEARCH INDEX

Corporate Membership Support

Please allow at least eight (8) weeks for the processing of your completed application.

Bristol-Myers Squibb provides support to national or regional disease-related organizations or medical societies that permit corporate memberships.

To be eligible for support, the organization must support activities that benefit the public, in addition to serving member interests. Corporate memberships must be a recognized membership category according to the organization’s bylaws, charter, or other guidelines. Exclusive memberships where BMS is the only corporate member are not permitted.

Corporate Membership support may not be tied, in any way, to past, present, or future prescribing, purchasing, or recommending (including formulary recommendations) of any drug. Any evidence that suggests that the Corporate Membership support or request for support is tied, in any way, to past, present, or future prescribing or recommending of any drug will cause the request to be rejected, and the request may not be resubmitted.

Before you start the submission process, please be sure to have the following information available:

1.
Federal Tax ID number for your organization
2.
Organizational Information
3.
Valid E-Mail address for communications
4.
Verification of your role within the requesting organization

Click here to begin the application process.

 




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy. CRISP#: ZN-I0241 12/2006

 

Our Medical Grants and Charitable Contributions program supports educational initiatives.
SEARCH INDEX